Showing results (3051-3060 of 6,521) with videos related to

Sort By:
Pageof 653
World Journal of Urology|March 7, 2024
Small intestinal submucosa graft bulbar urethroplasty is a viable technique: results compared to buccal mucosa graft urethroplasty after propensity score matchingEnzo Palminteri, Stefano Toso, Mirko Preto, et al.
World Journal of Urology|February 1, 2024
Development and outcomes of surgical and urological kidney transplantation programs in Germany: a total population analysis from 2006 to 2021Philipp Reimold, Cem Aksoy, Jonas Beckmann, et al.
World Journal of Urology|January 27, 2024
Is water vapor thermal therapy safe and feasible in elderly and frail men? The Italian experienceAntonio Minore, Simone Morselli, Francesco Franzoso, et al.
World Journal of Urology|January 27, 2024
Patients and general practitioner knowledge and perception of testicular self-examination for cancerQuentin Boisselier, Ugo Pinar, Xavier Durand, et al.
World Journal of Urology|July 26, 2023
A grading system for evaluation of bladder trabeculationXiao Wang, Hong-Song Chen, Chong Wang, et al.
World Journal of Urology|August 8, 2023
Urology: a trip into metaverseGianmarco Randazzo, Giuseppe Reitano, Filippo Carletti, et al.
World Journal of Urology|August 6, 2023
Initial experience of comparison between two slimmest single-use flexible ureteroscopes: Indoscope Sleek (Bioradmedisys™) Versus Uscope PU3033A (Pusen™): A single-center prospective studyShashank Agrawal, Pavan Survase, Abhishek G Singh, et al.
World Journal of Urology|August 4, 2023
Consultation on UTUC II Stockholm 2022: diagnostics, prognostication, and follow-up-where are we today?Filip Sydén, Joyce Baard, Matthew Bultitude, et al.
World Journal of Urology|July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trialThierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
World Journal of Urology|August 1, 2023
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancerKatharina Rebhan, Philipp D Stelzer, Benjamin Pradere, et al.
Pageof 653